期刊文献+

miRNA-152表达与NSCLC对顺铂耐药的关系及其机制研究 被引量:6

Relation between microRNA-152 expression and cisplatin resistance in non-small cell lung cancer cells and its mechanism
暂未订购
导出
摘要 目的研究微小RNA-152(miRNA-152)在非小细胞肺癌(NSCLC)顺铂(DDP)耐药过程中的作用机制。方法实时荧光定量逆转录PCR(qRT-PCR)检测NSCLC细胞株A549及其DDP耐药株A549/DDP细胞内的miRNA-152水平。通过转染miRNA-52模拟物(miRNA-152mimic)以提高A549/DDP细胞内的microRNA-152水平。MTT试验、倒置相差显微镜技仪和流式细胞术观察上调miRNA-152对细胞增殖及凋亡的影响,同时采用qRT-PCR和Western blot技术观察细胞内Bcl-2及核转录因子-κB(NF-κB)水平变化。结果 A549/DDP细胞中存在miRNA-152的低表达,Bcl-2及NF-κB的高表达。上调miRNA-152后,DDP造成的A549/DDP细胞增殖抑制率和凋亡率显著高于未上调miRNA-152的细胞,差异有统计学意义(P<0.05)。此外,miRNA-152mimic转染可显著降低A549/DDP细胞中的Bcl-2及NF-κB表达。结论低miRNA-152表达可能引起NSCLC对DDP的耐药,miRNA-152可能通过调节Bcl-2及NF-κB的水平介导NSCLC细胞对顺铂的敏感性。 Objective To investigate the action mechanism of microRNA-152(miRNA-152)in the cisplatin(DDP)resistance process in non-small cell lung cancer(NSCLC).Methods The miRNA-152 level in NSCLC cell line A549 and its cisplatin-resistant cell line A549/DDP was detected by the real time quantitative PCR(qRT-PCR).miRNA-152 mimic was transfected for increasing the intracellular miRNA-152 level in A549/DDP.The MTT assay,inverted miroscope technique and flow cytometry were adopted to observe the effect of up-regulating miRNA-152 on cell proliferation inhibition and apoptosis,meanwhile,the level changes of intracellular Bcl-2and NF-κB were also observed by adopting qRT-PCR and Western blot.Results The low expression of miRNA-152 and the high expression of Bcl-2and NF-κB were found in A549/DDP cells.Up-regulation of miRNA-152 enhanced the inhibitory effect of DDP in A549/DDP cells.Furthermore,after up-regulating miRNA-152,the inhibiting rate and apoptosis rate of A549/DDP cells caused by DDP were significantly higher than those in the cells without up-regulating miRNA-152,the difference was statistically significant(P〈0.05).In addition,miRNA-152 mimic transfection significantly decreased the expression of Bcl-2and NF-κB in A549/DDP cells.Conclusion Low expression of miRNA-152 may induce the resistance of NSCLC to DDP,miRNA-152 could mediate the sensitivity of NSCLC cells to DDP via regulating Bcl-2and NF-κB levels.
出处 《重庆医学》 CAS 北大核心 2016年第10期1297-1301,共5页 Chongqing medicine
关键词 非小细胞肺 微小RNAS Bcl-2 核因子ΚB 顺铂 药物耐受性 carcinoma non-small-cell lung microRNAs Bcl-2 NF-κB cisplatin drug tolerance
  • 相关文献

参考文献19

  • 1Kocher F, A Pircher,A Mohn-Staudner, et al. Multicenter phase II study evaluating docetaxel and cisplatin as neo- adjuvant induction regimen prior to surgery or radioche- motherapy with docetaxel,fol[owed by adjuvant docetaxel therapy in chemonaive patients with NSCLC stage 11 , HI A and I]1 B(TAX-AT I. 203 Trial) I-J]. Lung Cancer, 2014,85(3) :395-400.
  • 2Pircher A, Manzl C, Fiegl M, et al. Overcoming resistanceto first generation EGFR TKIs with cetuximab in combi- nation with chemotherapy in an EGFR mutated advanced stage NSCLC patient[J]. Lung Cancer, 2014,83 (3) .. 408- 410.
  • 3Rolfo C, Giovannetti E, Hong DS, et al. Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors[J]. Cancer Treat Rev, 2014,40(8) .. 990-1004.
  • 4Wu C, Wang Y, Xia Y, et al. Wilms~ tumor 1 enhances Cisplatin-resistance of advanced NSCLC[J]. FEBS Lett, 2014,588(24) : 4566-4572.
  • 5Su Y, Wang Y, Zhou H, et al. miRNA-152 targets AD- AM17 to suppress NSCLC progression[J]. FEBS Lett, 2014,588(10) : 1983-1988.
  • 6Li S, Lei Y, Jia Y, et al. Piperine, a piperidine alkaloid from Piper nigrum re-sensitizes P-gp, MRP1 and BCRP dependent multidrug resistant cancer cellsFJ]. Phytomed- icine,2011,19(1) :83-87.
  • 7Wang W, Liu G, Zheng J. Human renal UOK130 tumor cells..A drug resistant cell line with highly selective over- expression of glutathione S-transferase-Tr isozyme[J]. Eur J Pharmacol,2007,568(1/3) :61-67.
  • 8Heavey S,Barr M,Edwards C,et al. 7 NFkB-I~Ba interac- tion., a mechanism of resistance to cisplatin in NSCLC[J]. Lung Cancer,ZOlg, 75(12) :$3.
  • 9林高阳,徐克.MicroRNA调控肿瘤耐药的研究进展[J].中国肺癌杂志,2014,17(10):741-749. 被引量:10
  • 10崔秀英,郭运杰,姚和瑞.耐药乳腺癌细胞株MCF-7/ADR中microRNA的分析[J].南方医科大学学报,2008,28(10):1813-1815. 被引量:25

二级参考文献100

  • 1Grishok A, Pasquinelli AE, Conte D, et al. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing [J]. Cell, 2001, 106(1): 23-34.
  • 2Ambros V. MicroRNA pathways in flies and worms: growth, death, fat,stress ,and timing[J]. Cell, 2003, 113(6): 673-6.
  • 3Carrington JC, Ambros V. Role of microRNAs in plant and animal development[J]. Science, 2003, 301(5631): 336-8.
  • 4Calin GA, Dumitru CD, Shimizu M, et al.Frequent deletions and down-regulation ofmicro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia [J]. Proc Natl Acad Sci USA, 2002, 99(24): 15524-9.
  • 5Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2 [J]. Proc Natl Acad Sci USA, 2005, 102(39): 13944-9.
  • 6Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis [J].Cancer Cell, 2006, 9(3): 189-98.
  • 7Kovalchuk O, Tryndyak YP, Montgomery B, et al. Estrogen-induced rat breast carcinogenesis is characterized by alterations in DNA methylation, histone modifications and aberrant microRNA expression[J]. Cell Cycle, 2007, 6(16): 2010-8.
  • 8Tavazoie SF, Alarcon C, Oskarsson T, et al. Endogenous human microRNAs that suppress breast cancer metastasis [ J ]. Nature, 2008, 451(7175): 147-52.
  • 9Yu F, Yao H, Zhu P, et al. let-7 regulates self-renewal and tumorigenesis of breast cancer cells [J]. Cell, 2007, 131 (6): 1109-23.
  • 10Mishra PJ, Humeniuk R, Mishra PJ, et al. A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance [J]. Proe Natl Acad Sci USA, 2007, 104 (33): 13513-8.

共引文献57

同被引文献51

引证文献6

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部